Oncotect is a Raleigh-based biotech startup committed to pioneering early screening of cancer risks in dogs using their urine. The company’s patent-pending in-vitro scientific test combines its proprietary technology and C. elegans’ highly effective olfactory receptors to detect cancerous volatile metabolites. Oncotect is the only urine-based non-invasive, convenient, affordable, and accessible multi-cancer screening test available to dogs.
Looking for a particular Oncotect employee's phone or email?
Oncotect Questions
Chan Namgong is the Founder and CEO of Oncotect.
2 people are employed at Oncotect.
Oncotect is based in Raleigh, North Carolina.
Top Oncotect Employees
-
Chan Namgong
Founder and CEO at Oncotect
Raleigh, NC, US34 -
Jenna Marks
Laboratory Technician at Oncotect
Raleigh, NC, US
Related Companies
